Hulem C D, Old S E, Zeleznick L D, Leopold I H
Arch Ophthalmol. 1982 Apr;100(4):646-9. doi: 10.1001/archopht.1982.01030030648025.
Rosoxacin, a new synthetic antimicrobial agent, has a wide spectrum of activity that may prove beneficial in the treatment of ocular infections. To determine the penetration of rosoxacin into ocular tissues and serum of the rabbit after topical, subconjunctival, and intravenous (IV) administration, rosoxacin levels were measured using a microbiological assay after enzymatic digestion of the ocular tissues. Quantities of rosoxacin that should prove to be of therapeutic value were detectable in the anterior segment of the eye after topical or subconjunctival administration. Subconjunctival administration also resulted in high levels in the retina and choroid area and in the optic nerve. Low levels were detected in the retina and choroid 15 minutes following IV injection; however, no detectable levels were found in the ocular tissues after this period.
罗索沙星是一种新型合成抗菌剂,具有广泛的活性,可能对眼部感染的治疗有益。为了确定局部、结膜下和静脉注射(IV)给药后罗索沙星在兔眼组织和血清中的渗透情况,在对眼组织进行酶消化后,使用微生物测定法测量罗索沙星水平。局部或结膜下给药后,在眼前节可检测到具有治疗价值的罗索沙星量。结膜下给药还导致视网膜、脉络膜区域和视神经中的水平升高。静脉注射后15分钟,在视网膜和脉络膜中检测到低水平;然而,在此之后,在眼组织中未发现可检测到的水平。